Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,348 INR | +2.20% | +1.50% | +20.07% |
May. 14 | Transcript : Neuland Laboratories Limited, Q4 2024 Earnings Call, May 14, 2024 | |
May. 10 | Neuland Laboratories' Consolidated Profit Declines in Fiscal Q4 | MT |
Sales 2024 | 15.59B 188M | Sales 2025 * | 15.98B 192M | Capitalization | 81.45B 981M |
---|---|---|---|---|---|
Net income 2024 | 3B 36.14M | Net income 2025 * | 3.02B 36.33M | EV / Sales 2024 | 5.17 x |
Net cash position 2024 * | 2.32B 28M | Net cash position 2025 * | 3.57B 42.97M | EV / Sales 2025 * | 4.87 x |
P/E ratio 2024 |
26.9
x | P/E ratio 2025 * |
27.1
x | Employees | 1,554 |
Yield 2024 * |
0.19% | Yield 2025 * |
0.15% | Free-Float | 62.32% |
Latest transcript on Neuland Laboratories Limited
1 day | +2.20% | ||
1 week | +1.50% | ||
Current month | -16.48% | ||
1 month | -12.04% | ||
3 months | -9.35% | ||
6 months | +25.12% | ||
Current year | +20.07% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 01-12-31 | |
Abhijit Majumdar
DFI | Director of Finance/CFO | - | 22-11-22 |
Chief Tech/Sci/R&D Officer | - | Nov. 21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 22-10-30 | |
Director/Board Member | 80 | 19-02-11 | |
Sugata Sircar
BRD | Director/Board Member | 60 | 23-06-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 6,348 | +2.20% | 3,523 |
24-05-23 | 6,212 | -1.29% | 1,170 |
24-05-22 | 6,293 | +1.50% | 1,004 |
24-05-21 | 6,200 | -0.46% | 3,930 |
24-05-18 | 6,229 | -0.42% | 279 |
Delayed Quote Bombay S.E., May 24, 2024 at 06:26 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.07% | 981M | |
+38.51% | 727B | |
+33.05% | 599B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+16.00% | 243B | |
+8.09% | 205B | |
-5.77% | 203B | |
+6.19% | 164B |
- Stock Market
- Equities
- NEULANDLAB Stock